Raymond Prudo-Chlebosz

Insider Reports History

Entity
Individual
Location
71 Shepherds Hill, London, United Kingdom
Signature
/s/ Wendy F. DiCicco, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raymond Prudo-Chlebosz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 4.08B $4.89M $0.00 Dec 2, 2024 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 801M $961K $0.00 Dec 2, 2024 RPC Pharma Limited
Akari Therapeutics Plc Director Warrants (Right to Buy) 419M $503K $0.00 Dec 2, 2024 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 38.7M $46.5K $0.00 Dec 2, 2024 Praxis Trustees Limited
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 3.66B May 31, 2024 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 801M May 31, 2024 RPC Pharma Limited
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 38.7M May 31, 2024 Praxis Trustees Limited
Akari Therapeutics Plc Director Stock Option (Right to Buy) 10M Jun 28, 2024 Direct

Insider Reports Filed by Raymond Prudo-Chlebosz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKTX Akari Therapeutics Plc Dec 2, 2024 2 $1.01M 4 Dec 3, 2024 Director
AKTX Akari Therapeutics Plc Jun 28, 2024 1 $0 4 Jul 2, 2024 Director
AKTX Akari Therapeutics Plc May 31, 2024 2 $2.39M 4 Jun 4, 2024 Director
AKTX Akari Therapeutics Plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Director